Invention Grant
- Patent Title: Heteroaryl-substituted imidazole compounds and uses thereof
- Patent Title (中): 杂芳基取代的咪唑化合物及其用途
-
Application No.: US12383035Application Date: 2009-03-19
-
Publication No.: US08129394B2Publication Date: 2012-03-06
- Inventor: Zilin Hunag , Jeff Jin , Timothy Machajewski , William R. Antonios-McCrea , Maureen McKenna , Daniel Poon , Paul A. Renhowe , Martin Sendzik , Cynthia Shafer , Aaron Smith , Yongjin Xu , Qiong Zhang , Zheng Chen
- Applicant: Zilin Hunag , Jeff Jin , Timothy Machajewski , William R. Antonios-McCrea , Maureen McKenna , Daniel Poon , Paul A. Renhowe , Martin Sendzik , Cynthia Shafer , Aaron Smith , Yongjin Xu , Qiong Zhang , Zheng Chen
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michael G. Smith
- Main IPC: A61K31/4965
- IPC: A61K31/4965 ; A61K31/505 ; A01N43/54 ; C07D403/00 ; C07D401/00 ; C07D405/00 ; C07D409/00 ; C07D411/00 ; C07D413/00 ; C07D417/00 ; C07D419/00
Abstract:
Novel imidazole compounds of the general formula are disclosed, wherein R1 and R2 comprise heteroaryl groups. These compounds and compositions containing them are useful in methods to treat Raf kinase-mediated disorders such as cancer.
Public/Granted literature
- US20100003246A1 Novel heterocyclic compounds and uses therof Public/Granted day:2010-01-07
Information query
